Track where NIH funding is moving and who was funded recently.

Across the 12 research areas this site tracks — from Alzheimer’s disease to gene therapy — the snapshot contains $27.2B in matched funding totals for FY2025, +15% versus FY2021. That growth is unevenly distributed: long covid funding grew +332% and glp-1 funding grew +75%, while cvd moved +1% and obesity moved +2% over the same window.

The quieter story is concentration. FY2025 produced about 8% fewer matched award records than FY2024 across these areas even though total dollars rose — tracked funding is consolidating into fewer, larger grants. For applicants, that means average award size is rising, but so is the bar for winning one.

Mid–fiscal year, most dollars flowing are renewals of existing projects: non-competing continuations are issued early in the NIH fiscal year, while most new awards land in the spring and summer council rounds. If you are timing an application or scouting a funded lab, the per-topic briefs linked in the table break each area down by institute, mechanism, and recent awards.

How to read this: one award mentioning two tracked areas (for example diabetes and obesity) counts in both rows, so these are coverage figures for each area, not an NIH-wide total. Figures come from a committed snapshot of NIH RePORTER records — see our data methodology.